Beone Medicines Ltd
(ONC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -950,578 | -674,033 | -93,299 | -119,217 | -57,102 |
| Depreciation Amortization | 18,617 | 10,388 | 4,758 | 1,909 | 1,545 |
| Income taxes - deferred | -9,232 | -21,949 | -5,845 | -768 | N/A |
| Accounts receivable | -29,822 | -11,628 | -29,428 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,224 | 23,470 | 55,298 | 2,707 | 6,186 |
| Other Working Capital | -10,833 | -17,214 | 57,199 | 14,888 | 2,263 |
| Other Operating Activity | 229,355 | 143,249 | 24,069 | 10,968 | 7,265 |
| Operating Cash Flow | $-750,269 | $-547,717 | $12,752 | $-89,513 | $-39,843 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -89,612 | -108,581 | -46,374 | -23,498 | -5,313 |
| Purchase Of Investment | -1,169,300 | -2,635,686 | -741,296 | -382,093 | -119,291 |
| Sale Of Investment | 1,882,075 | 2,177,207 | 423,789 | 183,743 | 65,698 |
| Purchase Sale Intangibles | N/A | -553 | -12,354 | N/A | N/A |
| Other Investing Activity | -69,000 | -70,553 | 7,562 | 0 | 0 |
| Investing Cash Flow | $554,163 | $-637,613 | $-356,319 | $-221,848 | $-58,906 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 67,489 | N/A | 2,470 | N/A | N/A |
| Debt Issued | N/A | 42,315 | 132,757 | 12,048 | 6,175 |
| Debt Repayment | N/A | -8,736 | N/A | N/A | N/A |
| Common Stock Issued | 47,004 | 1,663,031 | 343,746 | 371,072 | 77 |
| Other Financing Activity | -28,813 | -6,073 | 11,383 | -2,218 | 96,953 |
| Financing Cash Flow | $85,680 | $1,690,537 | $490,356 | $380,902 | $103,205 |
| Exchange Rate Effect | -9,512 | -4,096 | 5,299 | 104 | -485 |
| Beginning Cash Position | 740,713 | 239,602 | 87,514 | 17,869 | 13,898 |
| End Cash Position | 620,775 | 740,713 | 239,602 | 87,514 | 17,869 |
| Net Cash Flow | $-119,938 | $501,111 | $152,088 | $69,645 | $3,971 |
| Free Cash Flow | |||||
| Operating Cash Flow | -750,269 | -547,717 | 12,752 | -89,513 | -39,843 |
| Capital Expenditure | -89,612 | -108,581 | -46,374 | -23,502 | -5,314 |
| Free Cash Flow | -839,881 | -656,298 | -33,622 | -113,015 | -45,157 |